About A4Cell
A4Cell is a company based in Madrid (Spain) founded in 2018. A4Cell has raised $5.4 million across 4 funding rounds from investors including European Union, BeAble Capital and Dreavent Capital. A4Cell offers products and services including CytoCHECK SPAchip® pH green Single-Detection Kit, CytoCHECK SPAchip® Calcium Single-Detection Kit, CytoCHECK SPAchip® OHrad ROS Single-Detection Kit, and CytoTRACK SPAchip® pH Dual-Detection Kit. A4Cell operates in a competitive market with competitors including 10X Genomics, Mission Bio, Cellares, LUMICKS and LevitasBio, among others.
- Headquarter Madrid, Spain
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Arrays For Cell Nanodevices S.L.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$5.4 M (USD)
in 4 rounds
-
Latest Funding Round
$3.26 M (USD), Series B
Nov 16, 2023
-
Investors
European Union
& 4 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of A4Cell
A4Cell offers a comprehensive portfolio of products and services, including CytoCHECK SPAchip® pH green Single-Detection Kit, CytoCHECK SPAchip® Calcium Single-Detection Kit, CytoCHECK SPAchip® OHrad ROS Single-Detection Kit, and CytoTRACK SPAchip® pH Dual-Detection Kit.
Monitors intracellular pH in living cells for real-time analysis.
Enables calcium monitoring in cellular signaling pathways.
Detects reactive oxygen species in cells for research purposes.
Facilitates dual pH monitoring in cellular processes.
People of A4Cell
Unlock access to complete
Funding Insights of A4Cell
A4Cell has successfully raised a total of $5.4M across 4 strategic funding rounds. The most recent funding activity was a Series B round of $3.26 million completed in November 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in A4Cell
A4Cell has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include European Union, BeAble Capital and Dreavent Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Seed and early stage energy and tech focused VC firm investing primarily in Spain
|
Locked | Locked | Locked | |
|
Biotech investments are managed by Dreavent Capital for innovation.
|
Locked | Locked | Locked | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked |
Investor details for A4Cell
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by A4Cell
Investment portfolio details for A4Cell
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - A4Cell
Detailed financials for A4Cell
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
A4cell Comparisons
Peer comparison for A4Cell
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of A4Cell
A4Cell operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as 10X Genomics, Mission Bio, Cellares, LUMICKS and LevitasBio, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Instrument systems for genomic research and sequencing libraries are developed.
|
|
| Locked | Locked | Locked |
Single-cell multi-omics platform is provided for genotypic and phenotypic analysis.
|
|
| Locked | Locked | Locked |
Medical devices for cell-based therapy manufacturing are produced.
|
|
| Locked | Locked | Locked |
Optical tweezers instruments for single-molecule analysis are manufactured.
|
|
| Locked | Locked | Locked |
Single-cell imaging platform developed via magnetic levitation technology.
|
|
| Locked | Locked | Locked |
An imaging system for single-cell gene analysis is developed.
|
Detailed competitors of A4Cell
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on A4cell
Complete news archive for A4Cell
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about A4Cell
A4Cell was founded in 2018 and raised its 1st funding round 1 year after it was founded.
A4Cell is headquartered in Madrid, Spain. It is registered at Madrid, Madrid, Spain.
Elena Rivas is the current CEO of A4Cell.
A4Cell is a funded company, having raised a total of $5.4M across 4 funding rounds to date.
A4Cell was established in 2018 in Madrid, Spain, within the biotechnology sector. Tools for examining live single cells are developed, including the SPAchip Technology. Cell behavior, physiology, and biomolecular interactions are analyzed through this approach. Responses from individual cells are tracked over extended periods. Research applications in cell monitoring are supported across operations.
A4Cell's top competitors include 10X Genomics, Mission Bio and Cellares.
A4Cell offers CytoCHECK SPAchip® pH green Single-Detection Kit, CytoCHECK SPAchip® Calcium Single-Detection Kit, CytoCHECK SPAchip® OHrad ROS Single-Detection Kit, and CytoTRACK SPAchip® pH Dual-Detection Kit.
A4Cell has 5 investors. Key investors include European Union, BeAble Capital, Dreavent Capital, Innvierte Economia Sostenible Sicc Sme, and Ideas de bomberossl.